Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)
Erstveröffentlichung
2021
Wissenschaftlicher Artikel
Published in
Journal of Clinical Oncology ; 39 (2021), 30. - S. 3318-3327. - ISSN 0732-183X. - eISSN 1527-7755
Link to publication
https://dx.doi.org/10.1200/JCO.20.02724Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: ACUTE MYELOID-LEUKEMIA | RISK MYELODYSPLASTIC SYNDROMES | MALIGNANCIES WORKING PARTY | SOCIETE FRANCAISE | SCORING SYSTEM | AZACITIDINE | CHEMOTHERAPY | SUBCOMMITTEE | EFFICACY | GREFFE[DDC subject group]: DDC 610 / Medicine & health